Drug Safety

Drug Safety

Patient safety is of paramount importance to Jazz Pharmaceuticals. It is our ethical and regulatory responsibility to monitor the safety of the medicines we develop from their preclinical stage through clinical testing and prescribing. Timely reporting to Drug Safety is critical to enable compliance with regulatory requirements.

If you are a patient reporting occurrence of adverse events or if you have questions about your condition, please contact your health care practitioner.

Reporting an Adverse Event or Product Complaint in North America

Please call 1-800-520-5568 to report an adverse event or a product complaint for Defitelio®, Erwinaze®, FazaClo®, Sunosi®, Vyxeos®, Xyrem®, Xywav or Zepzelca® in the U.S.; or Defitelio®, Erwinaze®, Kidrolase®, or Xyrem® in Canada.

Reporting an Adverse Event or Product Complaint in Europe and International

To report an adverse event or a product complaint for Defitelio®, Erwinase®, Kidrolase®, Sunosi® or Vyxeos® Liposomal, please call using one of the country-specific telephone numbers listed below.

Our Pharmacovigilance Privacy Notice outlines how Jazz Pharmaceuticals handles the processing of personal information when dealing with your adverse event report.

For inquiries in:

Dutch

 
+31 207176898
For inquiries in:

English

 
UK/Ireland: +44 8450305089
For inquiries in:

French

 
+33 176728925
For inquiries in:

German

 
+49 3056796128
For inquiries in:

Italian

 
+39 0687500850
For inquiries in:

Polish

 
+48 221253377
For inquiries in:

Portuguese

 
+351 308805626
For inquiries in:

Spanish

 
+34 914142493
For other inquiries in:

EUR/INT

 
+44 8450305089